PCM
CELG

Peregrine Capital Management’s Celgene Corp CELG Stock Holding History

Peregrine Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-115,334
Closed -$10.3M – 330
2018
Q1 		$10.3M Sell
115,334
-51,597
-31% -$4.95M 0.25% 144
2017
Q4 		$17.4M Buy
166,931
+12,145
+8% +$1.37M 0.41% 97
2017
Q3 		$22.6M Hold
154,786
– – 0.54% 63
2017
Q2 		$20.1M Buy
154,786
+13,571
+10% +$1.66M 0.5% 71
2017
Q1 		$17.5M Sell
141,215
-59,919
-30% -$7.17M 0.45% 83
2016
Q4 		$23.3M Hold
201,134
– – 0.6% 46
2016
Q3 		$21M Buy
+201,134
New +$21.8M 0.55% 63

Other funds holding CELG

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Peregrine Capital Management's CELG Position: Q2 2018 in Review

Peregrine Capital Management sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 115,334 shares — an estimated $10.3M sold.

Peregrine Capital Management first reported a position in CELG in Q3 2016 and held it in 7 quarters. The position peaked at $23.3M in Q4 2016. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • Peregrine Capital Management reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • Peregrine Capital Management sold 115,334 Celgene Corp shares in Q2 2018, an estimated $10.3M.
  • Peregrine Capital Management first reported a position in Celgene Corp in Q3 2016 and held it in 7 quarters.
  • Peregrine Capital Management's Celgene Corp position peaked at $23.3M in Q4 2016.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on Peregrine Capital Management's 13F filing for Q2 2018, filed 12 Jul 2018.